Encephalitis and AMPA receptor antibodies Novel findings in a case series of 22 patients

Neurology

Volumn 84, Issue 24, 2015, Pages 2403-2412

  Höftberger, Romana ^a,b   Van Sonderen, Agnes ^c,d   Leypoldt, Frank ^e   Houghton, David ^f   Geschwind, Michael ^a   Gelfand, Jeffrey ^g   Paredes, Mercedes ^g,h   Sabater, Lidia ^a   Saiz, Albert ^a   Titulaer, Maarten J ^c   Graus, Francesc ^a   Dalmau, Josep ^i,j  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d HAGA HOSPITAL   (Netherlands)

^e University Medical Center Schleswig   (Germany)

^f OCHSNER CLINIC FOUNDATION   (United States)

^g Memory and Aging Center   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j UNIVERSITY OF PENNSYLVANIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMPA RECEPTOR ANTIBODY; CYCLOPHOSPHAMIDE; IMMUNOGLOBULIN; RECEPTOR ANTIBODY; RITUXIMAB; STEROID; UNCLASSIFIED DRUG; AMPA RECEPTOR; AUTOANTIBODY; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 1; GLUTAMATE RECEPTOR IONOTROPIC, AMPA 2;

ADULT; AGED; ARTICLE; AUTOIMMUNITY; BIPOLAR DISORDER; BREAST TUMOR; CANCER THERAPY; CLINICAL ARTICLE; COMORBIDITY; ENCEPHALITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOTHERAPY; LUNG TUMOR; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; OVARY TERATOMA; PARANEOPLASTIC NEUROPATHY; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; SYMPTOMATOLOGY; THYMOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; VERY ELDERLY; YOUNG ADULT; BLOOD; BRAIN; CEREBROSPINAL FLUID; FOLLOW UP; HEK293 CELL LINE; IMMUNOLOGY; KAPLAN MEIER METHOD; PATHOLOGY; RETROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; BRAIN; COMORBIDITY; ENCEPHALITIS; FEMALE; FOLLOW-UP STUDIES; HEK293 CELLS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RECEPTORS, AMPA; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84931052269     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001682     Document Type: Article

References (21)

1. Sprengel R. Role of AMPA receptors in synaptic plasticity. Cell Tissue Res 2006;326:447-455.
2. Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-434.
3. Peng X, Hughes EG, Moscato EH, Parsons TD, Dalmau J, Balice-Gordon RJ. Cellular plasticity induced by anti-AMPA receptor encephalitis antibodies. Ann Neu-rol 2015;77:381-398.
4. Gleichman AJ, Panzer JA, Baumann BH, Dalmau J, Lynch DR. Antigenic and mechanistic characterization of anti-AMPA receptor encephalitis. Ann Clin Transl Neurol 2014;1:180-189.
5. Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 2010;74:265-267.
6. Graus F, Boronat A, Xifro X, et al. The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 2010;74:857-859.
7. Wei YC, Liu CH, Lin JJ, et al. Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol 2013;261:129-133.
8. Dogan Onugoren M, Deuretzbacher D, Haensch CA, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry Epub 2014 Oct 9.
9. 18FDG-PET in anti-AMPA receptor limbic encephalitis. J Neuroimmunol 2014;271:53-55.
10. Dalmau J, Gultekin SH, Voltz R, et al. Ma1, a novel neuron-and testis-specific protein, is recognized by the serum of patients with paraneoplastic neurological disorders. Brain 1999;122:27-39.
11. Hoftberger R, Dalmau J, Graus F. Clinical neuropathol-ogy practice guide 5-2012: updated guideline for the diagnosis of antineuronal antibodies. Clin Neuropathol 2012;31:337-341.
12. Graus F, Saiz A, Dalmau J. Antibodies and neuronal autoimmune disorders of the CNS. J Neurol 2010;257:509-517.
13. Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 2010;9:776-785.
14. Lancaster E, Huijbers MG, Bar V, et al. Investigations of caspr2, an autoantigen of encephalitis and neuromyotonia. Ann Neurol 2011;69:303-311.
15. Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098.
16. Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA (B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76.
17. Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neu-romyotonia. Brain 2010;133:2734-2748.
18. Hoftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013;81:1500-1506.
19. Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-165.
20. Fukata Y, Lovero KL, Iwanaga T, et al. Disruption of LGI1-linked synaptic complex causes abnormal synaptic transmission and epilepsy. Proc Natl Acad Sci USA 2010;107:3799-3804.
21. Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 2013;33:18161-18174.